Delirium, Dementia, Amnestic, Cognitive Disorders  >>  Campath (alemtuzumab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Campath (alemtuzumab) / Sanofi
NCT00668564: Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism

Terminated
2
18
US
Stem Cell Transplantation, Bone Marrow Transplant, cord blood transplant, Cyclophosphamide, Cytoxan, Campath-1H, Alemtuzamab, Busulfan, Busulfex
Masonic Cancer Center, University of Minnesota
Hurler's Syndrome, Maroteaux-Lamy Syndrome, Sly Syndrome, Alpha Mannosidosis, Fucosidosis, Aspartylglucosaminuria, Sphingolipidoses, Krabbe Disease, Wolman's Disease, Niemann-Pick Disease Type B, Niemann-Pick Disease, Type C
02/10
02/10

Download Options